During FY17-19, Radico enjoyed an earnings upcycle which has moderated in 9MFY20. However, co's focus on investing in new launches, driving premiumisation and deleveraging B/S has kept the growth momentum steady. Robust cash flow generation over the last 2 years (Rs 5bn cumulative FCF) was redeployed to repay debt (Rs 3.6bn in Dec-19 as compared to Rs 7.9bn in Mar-17). We expect deleveraging to sustain, making the co debt free by FY22. Healthy cash flow and deleveraging will re-rate the stock. Radico Khaitan saw a blockbuster performance in 3Q with P&A; saw 21% volume growth (beating estimates). Liquor industry facing multiple headwinds (slowdown, flooding, liquidity stress and policy changes) in 9MFY20, despite, Radico posted 16% P&A; volume growth to 5.5mn cases. Ease in RM inflation and sustaining healthy volume should re-rate the stock. We value Radico at 22x (45% discount to UNSP) on Dec-21 EPS, arriving at a TP of Rs 527. Maintain BUY.